UBS Group’s Barington/Hilco Acquisition Corp. BHAC Stock Holding History

UBS Group’s Portfolio BHAC Stock Details BHAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,160	Closed	-$13K	–	8763
2018 Q3	$13K	Hold	1,160	–	–	﹤0.01%	7057
2018 Q2	$12K	Sell	1,160 -700	-38%	-$7.55K	﹤0.01%	7066
2018 Q1	$20K	Hold	1,860	–	–	﹤0.01%	6436
2017 Q4	$19K	Sell	1,860 -40	-2%	-$420	﹤0.01%	6621
2017 Q3	$19K	Hold	1,900	–	–	﹤0.01%	6518
2017 Q2	$19K	Buy	+1,900	New	+$19.6K	﹤0.01%	6364
2015 Q4	–	Sell	-600	Closed	-$6K	–	9033
2015 Q3	$6K	Buy	+600	New	+$5.88K	﹤0.01%	7683

UBS Group's BHAC Position: Q4 2018 in Review

UBS Group sold out of Barington/Hilco Acquisition Corp. (BHAC) in Q4 2018, closing a stake of 1,160 shares — an estimated $13K sold.

UBS Group first reported a position in BHAC in Q3 2015 and held it in 7 quarters. The position peaked at $20K in Q1 2018. 0 funds tracked by Wall St. Rank hold BHAC as of Q4 2018.

UBS Group reported no remaining Barington/Hilco Acquisition Corp. position as of Q4 2018 after selling out during the quarter.
UBS Group sold 1,160 Barington/Hilco Acquisition Corp. shares in Q4 2018, an estimated $13K.
UBS Group first reported a position in Barington/Hilco Acquisition Corp. in Q3 2015 and held it in 7 quarters.
UBS Group's Barington/Hilco Acquisition Corp. position peaked at $20K in Q1 2018.
0 funds tracked by Wall St. Rank held Barington/Hilco Acquisition Corp. as of Q4 2018.

Based on UBS Group's 13F filing for Q4 2018, filed 14 Feb 2019.